Register for this webinar before July 10!
Webinar: Understanding and Navigating Long-Acting (injectable) HIV Treatment and Prevention Options in BC
Join Health Initiative for Men (HIM) , PAN and Ribbon Community for an overview of a new innovation in HIV treatment and prevention options. Health Canada has approved long-acting options for HIV treatment and prevention, and this is an opportunity to discuss exciting changes in how we can treat and prevent HIV.
Long-acting PrEP, called Apretude, is approved by Health Canada. However, it is not yet available through provincial or federal plans.
Two long-acting HIV treatments are approved by Health Canada and provided by the BC Centre for Excellence under specific circumstances on a case-by-case basis: Cabenuva and Sunlenca.
This webinar will empower frontline staff, educators, and community members with new information on long-acting HIV treatment and prevention options and highlight current realities for accessing long-acting medications in BC.
Wednesday July 10th, 2024
10 – 11:30 AM Pacific time
This webinar is scheduled for 90 minutes. Information on presenters to follow. We look forward to seeing you!
This webinar will support the work of:
- frontline service providers
- community educators
- community advocates
- people interested in HIV treatment and advocacy
Please note: As this webinar is being presented in partnership with Health Initiative for Men (HIM) and Ribbon Community, your registration information may be shared with these organizations.
Do you like this page?